← All Arcus Biosciences, INC filings

Arcus Biosciences, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
RCUS
Arcus Biosciences, INC
DEF: Arcus Biosciences Sets 2026 Annual Meeting Date
Arcus Biosciences, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 11, 2026, with key proposals including director elections and executive compensation.
NYSE
RCUS
Arcus Biosciences, INC
DEFA14A: Arcus Biosciences Sets Date for 2025 Annual Meeting, Proxy Materials Available
Arcus Biosciences announces its 2025 Annual Meeting of Stockholders to be held virtually on June 10, 2025, with proxy materials available online.
NYSE
RCUS
Arcus Biosciences, INC
DEF: Arcus Biosciences Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
Arcus Biosciences announces its 2025 Annual Meeting of Stockholders to be held virtually on June 10, 2025, featuring proposals for director elections, auditor ratification, and executive compensation approval.
NYSE
RCUS
Arcus Biosciences, INC
DEFA14A: Arcus Biosciences Announces 2024 Annual Meeting of Stockholders
Arcus Biosciences has scheduled its 2024 annual meeting of stockholders.
NYSE
RCUS
Arcus Biosciences, INC
DEF 14A: Arcus Biosciences Sets Date for 2024 Annual Stockholders Meeting
Arcus Biosciences will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, to vote on director elections, auditor ratification, and executive compensation.